These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 3141925)
1. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Talalay P; De Long MJ; Prochaska HJ Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8261-5. PubMed ID: 3141925 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Talalay P Adv Enzyme Regul; 1989; 28():237-50. PubMed ID: 2696344 [TBL] [Abstract][Full Text] [Related]
3. The potency of inducers of NAD(P)H:(quinone-acceptor) oxidoreductase parallels their efficiency as substrates for glutathione transferases. Structural and electronic correlations. Spencer SR; Xue LA; Klenz EM; Talalay P Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):711-7. PubMed ID: 1900000 [TBL] [Abstract][Full Text] [Related]
4. Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens. De Long MJ; Prochaska HJ; Talalay P Proc Natl Acad Sci U S A; 1986 Feb; 83(3):787-91. PubMed ID: 3080750 [TBL] [Abstract][Full Text] [Related]
5. Regulation of enzymes that detoxify the electrophilic forms of chemical carcinogens. Talalay P; Prochaska HJ; Spencer SR Princess Takamatsu Symp; 1990; 21():177-87. PubMed ID: 2134677 [TBL] [Abstract][Full Text] [Related]
6. On the mechanisms of induction of cancer-protective enzymes: a unifying proposal. Prochaska HJ; De Long MJ; Talalay P Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8232-6. PubMed ID: 3934671 [TBL] [Abstract][Full Text] [Related]
7. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Prochaska HJ; Talalay P Cancer Res; 1988 Sep; 48(17):4776-82. PubMed ID: 3409219 [TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid regulation of polycyclic aromatic hydrocarbon induction of cytochrome P450IA1, glutathione S-transferases, and NAD(P)H:quinone oxidoreductase in cultured fetal rat hepatocytes. Sherratt AJ; Banet DE; Prough RA Mol Pharmacol; 1990 Feb; 37(2):198-205. PubMed ID: 2304451 [TBL] [Abstract][Full Text] [Related]
9. Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers. Dinkova-Kostova AT; Abeygunawardana C; Talalay P J Med Chem; 1998 Dec; 41(26):5287-96. PubMed ID: 9857096 [TBL] [Abstract][Full Text] [Related]
10. Chemoprotection against cancer by phase 2 enzyme induction. Talalay P; Fahey JW; Holtzclaw WD; Prestera T; Zhang Y Toxicol Lett; 1995 Dec; 82-83():173-9. PubMed ID: 8597048 [TBL] [Abstract][Full Text] [Related]
11. Role of cytochrome P1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. De Long MJ; Santamaria AB; Talalay P Carcinogenesis; 1987 Oct; 8(10):1549-53. PubMed ID: 2820604 [TBL] [Abstract][Full Text] [Related]
12. Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro. Brooks JD; Goldberg MF; Nelson LA; Wu D; Nelson WG Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):868-75. PubMed ID: 12223431 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of glutathione transferase, glutathione transferase messenger RNA, and reduced nicotinamide adenine dinucleotide (phosphate):quinone reductase induction by 2(3)-tert-butyl-4-hydroxyanisole in mice. Benson AM; Hunkeler MJ; Morrow JF Cancer Res; 1984 Nov; 44(11):5256-61. PubMed ID: 6435866 [TBL] [Abstract][Full Text] [Related]
14. Induction of glutathione transferases and NAD(P)H:quinone reductase by fumaric acid derivatives in rodent cells and tissues. Spencer SR; Wilczak CA; Talalay P Cancer Res; 1990 Dec; 50(24):7871-5. PubMed ID: 2123743 [TBL] [Abstract][Full Text] [Related]
15. Induction of NAD(P)H:quinone reductase by probucol: a possible mechanism for protection against chemical carcinogenesis and toxicity. Iqbal M; Okada S Pharmacol Toxicol; 2003 Dec; 93(6):259-63. PubMed ID: 14675458 [TBL] [Abstract][Full Text] [Related]
16. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Dinkova-Kostova AT; Massiah MA; Bozak RE; Hicks RJ; Talalay P Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3404-9. PubMed ID: 11248091 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Zhang Y; Talalay P Cancer Res; 1998 Oct; 58(20):4632-9. PubMed ID: 9788615 [TBL] [Abstract][Full Text] [Related]
18. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Prestera T; Talalay P; Alam J; Ahn YI; Lee PJ; Choi AM Mol Med; 1995 Nov; 1(7):827-37. PubMed ID: 8612205 [TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. Kelly VP; Ellis EM; Manson MM; Chanas SA; Moffat GJ; McLeod R; Judah DJ; Neal GE; Hayes JD Cancer Res; 2000 Feb; 60(4):957-69. PubMed ID: 10706111 [TBL] [Abstract][Full Text] [Related]
20. [Induction of phase II enzymes as a strategy in the chemoprevention of cancer and other degenerative diseases]. Krajka-Kuźniak V Postepy Hig Med Dosw (Online); 2007 Oct; 61():627-38. PubMed ID: 17971764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]